Healio Minute Thursday, Feb. 27, 2014 Edition: Hepatitis C burden grows, ulcers respond to tissue repair drug, nasal pertussis vaccine tested
What just happened in medicine and why do you care?
Click Here to Manage Email Alerts
HCV prevalence, cost burden continue to rise
Healio.com/Hepatology: Panel concludes that the prevalence of hepatitis C cirrhosis in the United States has increased during the past 10 years and will continue to grow for the next decade. Read more.
Diabetic foot ulcers healed with tissue repair drug
Healio.com/Orthotics-Prosthetics: Polydeoxyribonucleotide increased the closure of foot ulcers in diabetic subjects after 8 weeks. Read more.
Investigational nasal pertussis vaccine shows promise
Healio.com/Infectious Disease: Findings indicate that the vaccine made from BPZE1, a genetically modified B. pertussis strain, may ultimately be useful in controlling pertussis in the target population, newborns. Read more.
Adhesive patch monitor identified arrhythmias in patients with stroke, TIA
Healio.com/Cardiology: Because many arrhythmias detected by the FDA-cleared, single-lead Zio Patch monitor occurred more than 48 hours after the start of monitoring, the device may be superior to the Holter monitor, researchers say. Read more.
Obesity declined in children aged 2 to 5 years; overall prevalence remains
Healio.com/Endocrinology: Along with the significant decline in obesity among young children, there was a significant increase in obesity among women aged at least 60 years. Read more.